A study carried out with a new human stem cell-derived model reveals that the most prevalent genetic risk factor of Alzheimer’s disease (AD), apolipoprotein E4 (APOE4), impairs the function of human brain immune cells, microglia. These findings pave the way for new, effective treatment approaches for AD.
Click here for original story, Alzheimer’s disease risk gene APOE4 impairs function of brain immune cells
Source: ScienceDaily